Navigation Links
Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical
Date:4/1/2009

ted States.

John A. MacPhee, President of Strativa Pharmaceuticals, said, "We believe that Nascobal Nasal Spray offers important benefits to people with a vitamin B12 deficiency. Given the large size of the prescription vitamin B12 market and Strativa's sales and marketing expertise, we believe that Nascobal is poised for significant growth."

Nascobal Nasal Spray, approved by the U.S. Food and Drug Administration in 2005, contains a synthetic form of vitamin B12 that is readily absorbed into the bloodstream through the nose and provides steady serum levels without the need for monthly injections received at the physician's office. Nascobal Nasal Spray's once-weekly dosing is convenient for patients and can minimize peaks and troughs in B12 serum levels that may be associated with monthly injections.

Nascobal Nasal Spray Safety Information

Nascobal(R) Nasal Spray is indicated for the maintenance of normal hematologic status in pernicious anemia patients who are in remission following intramuscular vitamin B12 therapy and who have no nervous system involvement. Nascobal Nasal Spray is also indicated as a supplement for other vitamin B12 deficiencies including: dietary deficiency of vitamin B12 occurring in strict vegetarian diets; malabsorption of vitamin B12 resulting from conditions including HIV infection, AIDS, and Crohn's disease; inadequate secretion of intrinsic factor resulting from lesions that destroy the gastric mucosa and other conditions associated with gastric atrophy including multiple sclerosis, HIV infection, AIDS, certain endocrine disorders, iron deficiency, and subtotal gastrectomy; total gastrectomy; competition for vitamin B12 by intestinal parasites or bacteria; and inadequate utilization of vitamin B12 that may occur if antimetabolites for the vitamin are employed in the treatment of neoplasia.

Nascobal Nasal Spray is contraindicated in patients with
'/>"/>

SOURCE Par Pharmaceutical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Strativa Pharmaceuticals Acquires Commercialization Rights to Thin Film Formulation of Ondansetron From MonoSol Rx
2. MonoSol Rx Licenses Thin Film Formulation of Ondansetron to Strativa Pharmaceuticals, a Division of Par Pharmaceutical
3. Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders
4. Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints
5. Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets
6. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
7. Meeting to examine FDA requirements for manufacturing PET radiopharmaceuticals
8. Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
9. Celator(R) Pharmaceuticals to Present at Future Leaders in the Biotech Industry Conference
10. Anadys Pharmaceuticals to Present at the Citi Biotech Day
11. Endo Pharmaceuticals Solutions (Formerly Indevus Pharmaceuticals, Inc.) Announces Commencement of Offer to Purchase Its 6.25% Convertible Senior Notes Due 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... When author Faith Canter was diagnosed ... if nothing could wake her up - and she wasn’t ... are currently living with CFS. , Rather than accepting her ... Living a Life Less Toxic : The Whole Life Approach ... Happier, Healthier Life for You, Your Family and Our Planet.” ...
(Date:4/20/2015)... Heritage Woods of Centralia, a Gardant ... and Dine-and-Dash Spaghetti Dinner from 4 p.m. to 6 ... located in Centralia, Illinois, houses senior living apartments, affordable ... 55 and older. , Guests are invited to tour ... options for seniors. After the tours, they can take ...
(Date:4/20/2015)... 2015 Construction has reached completion ... Draft, an independent, nonprofit community hospital with existing ... The project was an ongoing collaboration between Timmons ... is expected to provide additional employment opportunities for ... Highway, the new facility features physician offices, a ...
(Date:4/20/2015)... April 21, 2015 Using Quality by ... Speed Production and Improve Compliance , **FDAnews Webinar**, May ... http://www.fdanews.com/qualitybydesign , The life sciences industries are ... to do more with less. Mergers, acquisitions, the ... to finds ways to speed up production while still ...
(Date:4/20/2015)... Is it possible to create measures of ... the local needs of the providers, payers and patients who ... over the past year by the Hutchinson Institute for Cancer ... Center in Seattle, Washington. , In a new commentary ... Journal of Managed Care, HICOR Director Scott Ramsey, MD, ...
Breaking Medicine News(10 mins):Health News:New book by Faith Canter offers guide to banishing toxins 2Health News:Heritage Woods of Centralia Senior Living Community to Host Open House and Spaghetti Dinner 2Health News:Augusta Health Construction Wraps Up at Stuarts Draft 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 3Health News:Creating Value Metrics in Cancer Care From the Bottom Up 2Health News:Creating Value Metrics in Cancer Care From the Bottom Up 3
... to a major disaster should focus on three consecutive missions: ... aid, according to research presented Sunday, Oct. 3, at the ... San Francisco. In January, within 24 hours of ... States Naval Ship (USNS) Comfort was deployed to Haiti. With ...
... was higher among adults in Puerto Rico compared to ... was lower, according to data presented at the Third ... held Sept. 30 to Oct 3, 2010. Genetic ... and other venues, providing individual access to genetic tests ...
... Hopkins Medicine, Johns Hopkins scientists have discovered a way to ... proteins in mice, a discovery that could have implications for ... such as peanuts and milk. The findings, published online ... the body could be trained to tolerate food allergies that ...
... instrument due to fly aboard NASA,s James Webb Space Telescope ... facilities at the Rutherford Appleton Laboratory (RAL) in the United ... to areas of investigation as diverse as the first light ... other stars. "The start of space simulation testing ...
... A UC Irvine infectious disease specialist has received a ... methods to prevent staph infections in people who harbor MRSA ... Agency for Healthcare Research & Quality awarded Huang the grant ... American Recovery & Reinvestment Act of 2009. CHOICE grants will ...
... Boston Medical Center (BMC) doctors have proven the ... tool that assesses the cleanliness of the colon during ... of the journal Gastrointestinal Endoscopy , demonstrates the ... to rate colon cleanliness during colonoscopy. Audrey ...
Cached Medicine News:Health News:Operation Unified Response: 3 phases of disaster care in Haiti 2Health News:Adults in Puerto Rico aware of genetic testing, but use remains low 2Health News:Johns Hopkins researchers turn off severe food allergies in mice 2Health News:NASA's Webb telescope MIRI instrument takes one step closer to space 2Health News:NASA's Webb telescope MIRI instrument takes one step closer to space 3Health News:NASA's Webb telescope MIRI instrument takes one step closer to space 4Health News:UCI gets major funding to study ways of preventing drug-resistant staph infections 2Health News:Boston Medical Center research study validates the Boston Bowel Preparation Scale 2
(Date:4/20/2015)... KUALA LUMPUR, Malaysia , April 20, 2015 /PRNewswire/ ... 2015, resulting in a scarcity of opportunities for generic ... drug manufacturers in the region are looking beyond the ... the quality of existing drugs. Certain established generic manufacturers ... research and development of new molecules, although the impact ...
(Date:4/20/2015)... , April 21, 2015  Following is the ... LIFESAVING MEDICINE ... most important medicines — insulin —became available for general ... millions of people suffering from diabetes. Insulin is a ... the processing of carbohydrates in the human body. It ...
(Date:4/20/2015)... -- This report analyzes the worldwide markets for Breast Pumps ... Pumps, and Powered Breast Pumps. The report provides separate comprehensive ... Japan , Europe , ... and forecasts are provided for the period 2014 through 2020. ... Market data and analytics are derived from primary and secondary ...
Breaking Medicine Technology:Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 2Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 3Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 4Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 5U.S. Census Bureau Daily Feature for April 21 2World Breast Pumps Industry 2World Breast Pumps Industry 3World Breast Pumps Industry 4World Breast Pumps Industry 5World Breast Pumps Industry 6World Breast Pumps Industry 7World Breast Pumps Industry 8World Breast Pumps Industry 9World Breast Pumps Industry 10World Breast Pumps Industry 11World Breast Pumps Industry 12World Breast Pumps Industry 13World Breast Pumps Industry 14
... Inc. (Nasdaq: STRM ) today announced financial ... ended January 31, 2011. Highlights for the ... purchase contracts for add-on licenses with existing clients totaling ... recognized during the quarter; Company completed and ...
... N.J., April 12, 2011 Novartis Pharmaceuticals Corporation ... Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) ... treatment of patients with advanced neuroendocrine tumors (NET) ... provided after presentation of data from the everolimus ...
Cached Medicine Technology:Streamline Health® Solutions Reports Q4 Results 2Streamline Health® Solutions Reports Q4 Results 3Streamline Health® Solutions Reports Q4 Results 4Streamline Health® Solutions Reports Q4 Results 5Streamline Health® Solutions Reports Q4 Results 6Streamline Health® Solutions Reports Q4 Results 7Streamline Health® Solutions Reports Q4 Results 8Streamline Health® Solutions Reports Q4 Results 9Streamline Health® Solutions Reports Q4 Results 10Streamline Health® Solutions Reports Q4 Results 11Streamline Health® Solutions Reports Q4 Results 12Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 3Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 4Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 5Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 6Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 7Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 8Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 9Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 10
... SureFlex™ line of reusable and autoclavable Lithotripsy ... This revolutionary and patented termination method accepts ... In the unlikely event you do manage ... face absolutely prevents damage to your laser ...
ELVeS™ (Endo Laser Vein System) from biolitec is a versatile, easy to use & complete system that allows you to treat all conditions resulting from venous incompetence. (ELVeS has FDA clearance ...
Up-tapered output compresses NA to give low NA fiber performance on high NA fiber stock....
One piece, 100% fused silica construction offers low scatter and high efficiency...
Medicine Products: